trending Market Intelligence /marketintelligence/en/news-insights/trending/l1nbi86wcyw0inmd73xgzg2 content esgSubNav
In This List

Castlight Health issues FY'18 guidance

Blog

Fintech Intelligence Digital Newsletter: May 2021

Podcast

Street Talk Episode 76: Record pace of fintech M&A, funding in Q1'21 has legs

Street Talk – Episode 76: Record pace of fintech M&A, funding in Q1'21 has legs

Fintech Intelligence Digital Newsletter: April 2021


Castlight Health issues FY'18 guidance

Castlight Health Inc issued its financial guidance for 2018 and its results for the fourth quarter and full year 2017.

It expects to see a non-GAAP net loss per share of approximately 11 cents to 15 cents and a non-GAAP operating loss in the range of $15 million to $20 million. The company projected GAAP revenue between $150 million and $155 million.

The consensus normalized EPS estimate for 2018 is a net loss of 13 cents, according to S&P Capital IQ.

Castlight Health reported a net loss of $8.6 million, or a net loss of 6 cents per share, in the fourth quarter of 2017, a slight improvement from a net loss of $9.1 million, or a net loss of 9 cents, in the previous-year period.

Non-GAAP net loss was $5.7 million, or a net loss of 4 cents per share, in the last three months of 2017, compared to a net loss of $1.4 million, or a net loss of 1 cent per share, in the prior-year quarter.

The S&P Capital IQ consensus normalized EPS estimate for the fourth quarter of 2017 was a net loss of 5 cents.

For full year 2017, the company had a non-GAAP net loss of $27.3 million, or a net loss of 22 cents per share, compared to a net loss of $30.2 million, or a net loss of 30 cents per share, in 2016.

The consensus normalized EPS estimate for 2017 was a net loss of 23 cents, according to S&P Capital IQ.